CANary health technologies leadership
Raj Reddy
President & CEO
Raj has extensive experience in pharmaceutical science, nanoparticle drug encoding systems, and clinical risk management programs for specialty biological pharmaceuticals. As a registered pharmacist and an expert in strategic bio-science management, he has led the development of innovative pulmonary oncology adherence programs for some of the largest life science companies. With five published nanotechnology patents, Raj is the inventor of Canary’s breath decoding technology.
Dr Jennifer Murdoch, PhD
Chief of Health Systems Transformation
Jennifer is an expert in health systems and collaborative health care outcome models. Jennifer has held leadership roles in hospitals, governments and primary health care clinics, providing direction for health human resources strategies and integrated plans. Jennifer works with Sanjay on managing clinical trials and leads on strategies for health systems product adoption and outcome impacts.
Peter Harkin
SVP, Financial Operations
Peter is an accomplished international CFO/COO with strategic & operational experience in transforming VC & PE backed technology businesses. He brings a wealth of experience to his role of providing strategic leadership in the planning and implementation of financial operations and corporate finance. Peter is currently also a non-executive director of an Asian focused Venture Capital fund. Peter holds a MBA in Advanced Finance.
Anna Wang
SVP, Corporate Affairs & Strategic Partnerships
Anna is a global health and advocacy expert with 15 years of experience in drugs and medical device product development, developing partnerships and expanding footprint in developing markets. Anna was VP for Public Affairs at Medicines for Malaria and a senior advisor to the Bill & Melinda Gates Foundation. Anna also advises family offices, philanthropic and impact investment funds.
Dr Sanjay Gandhi, MD
Chief Medical Officer
Sanjay Gandhi is a physician executive and a board certified Interventional Cardiologists with over 15 years of experience in interventional cardiology, clinical trials, service line operations, and hospital strategy in academic institutions. He is an Associate Professor of Medicine at Case Western Reserve University in Cleveland and serves as the President of the Ohio Chapter of American College of Cardiology. He holds a Master of Business Administration degree with high honors from University of Michigan. He is passionate about leading healthcare technology startups reach their full potential and achieve clinical validation.
Dr Purav Badani, PhD
Head Scientist
Purav leads the R&D strategy. An expert in molecular modeling and reaction dynamics, and nanomaterial science, he is published internationally and has done rextensive research in mass spectrometry with volatile organic compounds (VOC’s) Additionally, he has been a gold medal winner in chemistry and a senior fellow in atomic energy research. His work in computational and theoretical science involved mapping the dissociation/ ionization dynamics of VOC’s.